Does sodium nitroprusside improve tissue oxygenation during cardiopulmonary bypass?

Area of Science:

• Cardiovascular Surgery
• Anesthesiology
• Physiology

Background:

• Cardiopulmonary bypass (CPB) with hypothermia is used in cardiac surgery.
• Maintaining adequate oxygen delivery and metabolism during CPB is crucial.
• Sodium nitroprusside (SNP) is a vasodilator used to manage blood pressure.

Purpose of the Study:

• To investigate the effect of sodium nitroprusside (SNP) on oxygen consumption during hypothermic cardiopulmonary bypass.
• To assess the impact of SNP on blood lactate concentrations in patients undergoing CPB.

Main Methods:

• Eight patients undergoing CPB with hypothermia were included.
• SNP was infused during the hypothermic phase of CPB.
• Whole-body oxygen consumption and blood lactate levels were measured during SNP infusion and control periods.

Main Results:

• SNP caused a significant reduction in arterial blood pressure.
• No significant changes in whole-body oxygen consumption were observed.
• Blood lactate concentrations remained unchanged during SNP infusion.

Conclusions:

• Sodium nitroprusside does not appear to significantly affect whole-body oxygen consumption or lactate levels during hypothermic CPB.
• The use of SNP during this phase of CPB may not influence critical metabolic parameters.
• Further research may be needed to fully elucidate the metabolic effects of vasodilators in CPB.